Re: OB: Mixed Reviews On Drug To Prevent Preterm Birth

From: Charlie Chambers (ricechaz@earthlink.net)
Tue Aug 29 13:46:28 2006


I wonder how much more they are going to charge for brand name progesterone.

On Aug 29, 2006, at 10:38 AM, art fougner, md wrote:

> A drug to help women carry their babies to term that is awaiting
> federal
> approval doesn't appear to delay the earliest preterm births most
> often
> linked to death and serious health problems, according to federal
> documents released yesterday.
>
> The results of a single clinical trial were not "statistically
> persuasive" in suggesting that the injectable drug, Gestiva, reduced
> births before either 32 or 35 weeks' gestation, Food and Drug
> Administration documents show.
>
> However, the drug does appear to reduce births before the 37th week,
> considered the cutoff point for a newborn to be considered premature,
> study results suggest. Adeza Biomedical Corp. said in FDA filings
> that
> weekly injections of Gestiva lead to a "substantial reduction" in
> preterm births among women most at risk.
>
> http://www.newsday.com/news/health/ny-
> hspree294869380aug29,0,5906224.story
>
> Art
>
> --
> art fougner, md
> "May The Wings of Liberty Never Lose a Feather." - Jack Burton





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:44:36 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.